GENOME ANNOUNCEMENT
===================

*Streptococcus agalactiae* is well-adapted to asymptomatic colonization in the gastrointestinal and genitourinary tracts of healthy individuals ([@B1]). However, under certain circumstances, it may turn into a life-threatening pathogen causing septicemia, meningitis, and pneumonia in neonates ([@B2]). It is also a serious cause of mortality and morbidity in nonpregnant adults, particurly in elderly persons and those with underlying diseases ([@B3]). Here, we report the draft genome sequence of the *S. agalactiae* PR06 isolate from a local hospital in Malaysia.

*S. agalactiae* PR06 was grown in Todd-Hewitt broth under optimal growth conditions. Gram stain and biochemical tests were performed to determine the purity of the bacterium. The genomic DNA of *S. agalactiae* PR06 was isolated using the Wizard genomic DNA purification kit (Promega). The draft genome of local *S. agalactiae* PR06 was determined using the Genome Analyzer IIx platform (Illumina). This genome was sequenced to produce ultra-deep coverage of 1,000×, and the quality was checked using FastQC. The reads were trimmed using the CLC bio Genomic Workbench 5.1 and assembled by mapping against the genome of the closest reference strain, *S. agalactiae* A909. A total of 67 contigs were produced, and these contigs were ordered with respect to the best-aligned positions compared to the reference genome of *S. agalactiae* A909 using Optimal Syntenic Layout of Unfinished Assemblies (OSLay) ([@B4]). The genome was annotated using the Rapid Annotations using Subsystems Technology (RAST) server ([@B5]), and putative coding sequences (CDSs) and annotated genes were identified by comparing outputs from the Bacterial Annotation System (BASys) ([@B6]).

The draft genome of *S. agalactiae* contains a circular chromosome of 2,120,750 bp with a G+C content of 37% and 2,143 protein-coding sequences. The genome revealed \>37 RNA genes and several virulence genes, including the *cyl* locus, which is responsible for pulmonary epithelial cell damage; the *cfb* gene, which codes for CAMP factor ([@B7]); the *scp* gene, which codes for C5a peptidase ([@B8]); and gene loci involved in capsule synthesis.

These observations and comparative genomic studies would be useful in providing better knowledge of the genetic and molecular elements that might reveal drug-resistance profiles and vulnerabilities. The genome offers targets for the development of diagnostic tests, as well as new antimicrobial drugs and vaccines.

Nucleotide sequence accession number. {#h1}
-------------------------------------

The genome sequence of *S. agalactiae* PR06 has been deposited at DDBJ/EMBL/GenBank under the accession no. [AOSD00000000](AOSD00000000).
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